33,551 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Roche Acquisitions

Roche has acquired 33 companies and its latest acquisition was Poseida Therapeutics, Inc. on Nov 2024

Unlock 30 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Poseida Therapeutics, Inc.

Nov 2024

Source »
$1.5B
Poseida is a California-based biopharmaceutical company that researches and develops gene therapies for the treatment of cancer and genetic diseases.

-

LumiraDx's Point of Care Diagnostics Platform Business

Dec 2023

Source »
$295M
-
Carmot Therapeutics, Inc.

Dec 2023

Source »
$2.7B
Carmot is a California-based biotechnology company that researches and develops novel therapeutics for the treatment of metabolic diseases,
Telavant, Inc.

Oct 2023

Source »
$7.1B
Telavant is a New York-based biotechnology company that researches and develops novel therapeutics for the treatment of inflammatory and fibrotic diseases.
Good Therapeutics, Inc.

Sep 2022

Source »
$250M
Good Therapeutics is a Washington-based biopharmaceutical company that develops and commercializes protein-based drugs for the treatment of cancer and autoimmune diseases.

Frequently Asked Questions about Roche

  1. What companies did Roche acquire?

    Companies acquired by Roche include Poseida, and Carmot

  2. How many acquisitions does Roche have?

    Roche has acquired 33 companies including Poseida, and Carmot.

  1. How many acquisitions did Roche make in 2024?

    In 2024 Roche acquired 1 companies including Poseida.